97 related articles for article (PubMed ID: 1742738)
1. Antitumor activity of gamma-interferon in ascitic and solid tumor models of human ovarian cancer.
Malik ST; Knowles RG; East N; Lando D; Stamp G; Balkwill FR
Cancer Res; 1991 Dec; 51(24):6643-9. PubMed ID: 1742738
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the antitumor activity of recombinant human gamma-interferon employing human melanoma xenografts in athymic nude mice.
Trotta PP; Harrison SD
Cancer Res; 1987 Oct; 47(20):5347-53. PubMed ID: 3115565
[TBL] [Abstract][Full Text] [Related]
3. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
Gridley DS; Slater JM; Stickney DR
J Biol Response Mod; 1989 Dec; 8(6):593-602. PubMed ID: 2513378
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro.
Wall L; Burke F; Barton C; Smyth J; Balkwill F
Clin Cancer Res; 2003 Jul; 9(7):2487-96. PubMed ID: 12855622
[TBL] [Abstract][Full Text] [Related]
5. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
Giavazzi R; Garofalo A; Ferri C; Lucchini V; Bone EA; Chiari S; Brown PD; Nicoletti MI; Taraboletti G
Clin Cancer Res; 1998 Apr; 4(4):985-92. PubMed ID: 9563894
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a human ovarian carcinoma cell line: UCI 101.
Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
9. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.
Mills GB; May C; Hill M; Campbell S; Shaw P; Marks A
J Clin Invest; 1990 Sep; 86(3):851-5. PubMed ID: 2394835
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer.
Balkwill FR; Ward BG; Moodie E; Fiers W
Cancer Res; 1987 Sep; 47(18):4755-8. PubMed ID: 3113722
[TBL] [Abstract][Full Text] [Related]
11. Interferon gamma is highly effective against orthotopically-implanted human pleural adenocarcinoma in nude mice.
An Z; Wang X; Astoul P; Danays T; Moossa AR; Hoffman RM
Anticancer Res; 1996; 16(5A):2545-51. PubMed ID: 8917349
[TBL] [Abstract][Full Text] [Related]
12. [Human ovarian epithelial adenocarcinoma with peritoneal metastasis and ascites established in murine models].
Li WJ; Qian HN
Zhonghua Fu Chan Ke Za Zhi; 1993 Jan; 28(1):38-40, 61. PubMed ID: 8504709
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma].
Kikuchi Y; Miyauchi M; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):121-8. PubMed ID: 2313142
[TBL] [Abstract][Full Text] [Related]
14. Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy.
De Cesare M; Calcaterra C; Pratesi G; Gatti L; Zunino F; Mènard S; Balsari A
Clin Cancer Res; 2008 Sep; 14(17):5512-8. PubMed ID: 18765543
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
[TBL] [Abstract][Full Text] [Related]
17. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
18. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.
Pearson JW; Fogler WE; Volker K; Riggs CW; Gruys E; Groves ES; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1993 Jun; 85(11):907-12. PubMed ID: 8492319
[TBL] [Abstract][Full Text] [Related]
19. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.
Allavena P; Peccatori F; Maggioni D; Erroi A; Sironi M; Colombo N; Lissoni A; Galazka A; Meiers W; Mangioni C
Cancer Res; 1990 Nov; 50(22):7318-23. PubMed ID: 2121337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
